Keywords: morphosys/bayer, extend, accord, upto, yrs, german, antibody

Morphosys/Bayer to extend accord upto 5 yrs

Article | 12 December 2005

Print This

German antibody developer MorphoSys AG has extended its collaboration with German drug major Bayer by another five years, with a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in